466
Participants
Start Date
June 9, 2021
Primary Completion Date
May 24, 2024
Study Completion Date
August 1, 2025
Placebo
"* Pharmaceutical form: Solution for infusion~* Route of administration: Intravenous infusion~Participants will receive Placebo during the Double-blind Treatment Period."
Bepranemab
"* Pharmaceutical form: Solution for infusion~* Route of administration: Intravenous infusion~Participants will receive pre-specified doses of bepranemab during the Double-blind Treatment Period and the Open-label Extension Period."
Ah0003 50424, Fairfax
Ah0003 50432, Norfolk
Ah0003 50479, Decatur
Ah0003 50457, Port Orange
Ah0003 50438, Pensacola
Ah0003 50623, Pensacola
Ah0003 50426, Maitland
Ah0003 50436, Hialeah
Ah0003 50427, Miami
Ah0003 50446, Westchester
Ah0003 50449, Aventura
Ah0003 50444, West Palm Beach
Ah0003 50476, West Palm Beach
Ah0003 50430, Delray Beach
Ah0003 50465, Atlantis
Ah0003 50435, Boca Raton
Ah0003 50454, Tampa
Ah0003 50429, Fort Myers
Ah0003 50478, Naples
Ah0003 50464, Ocoee
Ah0003 50455, Cordova
Ah0003 50451, Cincinnati
Ah0003 50448, Saint Paul
Ah0003 50380, Houston
Ah0003 50458, Long Beach
Ah0003 50452, Pasadena
Ah0003 50447, San Diego
Ah0003 50442, Irvine
Ah0003 50434, Santa Ana
Ah0003 50431, Fullerton
Ah0003 50428, Fresno
Ah0003 50450, Palo Alto
Ah0003 50440, Bellevue
Ah0003 50422, New Haven
Ah0003 50467, New Haven
Ah0003 50421, Stamford
Ah0003 50445, Braintree
Ah0003 50453, Newton
Ah0003 50420, Neptune City
Ah0003 50423, East Providence
Ah0003 40123, Brussels
Ah0003 40575, Brussels
Ah0003 40576, Kortrijk
Ah0003 40002, Leuven
Ah0003 50463, Kelowna
Ah0003 50461, Ottawa
Ah0003 50520, Québec
Ah0003 50045, Toronto
Ah0003 50291, Toronto
Ah0003 50462, Toronto
Ah0003 50522, West Vancouver
Ah0003 40129, Bordeaux
Ah0003 40580, Bron
Ah0003 40493, Marseille
Ah0003 40635, Nantes
Ah0003 40578, Paris
Ah0003 40201, Rennes
Ah0003 40581, Toulouse
Ah0003 40579, Villeurbanne
Ah0003 40028, Berlin
Ah0003 40430, Munich
Ah0003 40371, Monza
Ah0003 40600, Parma
Ah0003 40597, Pavia
Ah0003 40438, Roma
Ah0003 40596, Rome
Ah0003 40598, Rome
Ah0003 40449, 's-Hertogenbosch
Ah0003 40450, Amsterdam
Ah0003 40601, Zwolle
Ah0003 40603, Bialystok
Ah0003 40606, Bydgoszcz
Ah0003 40605, Katowice
Ah0003 40609, Katowice
Ah0003 40774, Katowice
Ah0003 40608, Szczecin
Ah0003 40638, Ścinawa
Ah0003 40602, Warsaw
Ah0003 40604, Warsaw
Ah0003 40607, Warsaw
Ah0003 40611, Wroclaw
Ah0003 40159, Barcelona
Ah0003 40160, Barcelona
Ah0003 40267, Barcelona
Ah0003 40612, Barcelona
Ah0003 40105, Córdoba
Ah0003 40614, Donostia / San Sebastian
Ah0003 40540, Madrid
Ah0003 40615, Madrid
Ah0003 40352, Pamplona
Ah0003 40280, Sant Cugat del Vallès
Ah0003 40049, Seville
Ah0003 40453, Terrassa
Ah0003 40230, Valencia
Ah0003 40613, Valencia
Ah0003 40616, Zaragoza
Ah0003 40662, Birmingham
Ah0003 40619, Bristol
Ah0003 40622, Guildford
Ah0003 40618, London
Ah0003 40621, London
Ah0003 40623, Plymouth
Ah0003 40691, Winchester
UCB Biopharma SRL
INDUSTRY